NEW YORK (Reuters Health) – Despite the supposed advantage of off-pump coronary artery bypass grafting for elderly patients with ischemic heart disease, a Danish study found no significant…
NEW YORK (Reuters Health) – After a standard course of combination chemotherapy for advanced non-small-cell lung cancer, maintenance therapy with a single agent improves overall survival and progression-free…
NEW YORK (Reuters Health) – The decline in cognitive function in children with Prader-Willi syndrome can be stabilized with ongoing growth-hormone (GH) therapy, a Dutch team reports in…
NEW YORK (Reuters Health) – Blood pressure lowering provides protection against intracranial bleeding in patients with cerebrovascular disease, including those on antithrombotic therapy, according to results of a…
NEW YORK (Reuters Health) – Nutritional support, mainly in the form of oral nutritional supplements, boosts protein and energy intake, body weight and grip strength in malnourished patients…
NEW YORK (Reuters Health) – Patients with advanced non-small-cell lung cancer have higher response rates to a regimen that includes an albumin-bound formulation of paclitaxel (nab-paclitaxel) than solvent-based…
NEW YORK (Reuters Health) – In African Americans with moderate-to-severe asthma, treatment for a year with an inhaled combination of budesonide and formoterol is safe and reduces asthma…
NEW YORK (Reuters Health) – Results of a new meta-analysis indicate that for patients with atrial fibrillation, treatment with one of the new oral anticoagulants rather than warfarin…
NEW YORK (Reuters Health) – For patients on maintenance prasugrel (Effient) therapy having percutaneous coronary intervention (PCI), a dose of 60 mg in the peri-PCI period achieves “faster…
NEW YORK (Reuters Health) – Adding the investigational agent perampanel to concomitant antiepilepsy therapy reduces seizure frequency in patients with refractory partial-onset seizures, according to the results of…
